The effect of isoenzyme-selective PDE inhibitors on methacholine-induced contraction of guinea-pig and rat ileum

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 2131-2139

  Tomkinson, Adrian ^a   Raeburn, David ^a  

^a SANOFI   (France)

Author keywords

Cyclic AMP; Cyclic GMP; Enprofyll ine; Gastrointestinal smooth muscle; Ileum; PDE inhibitors; Rolipram; Siguazodan; Vinpocetine; Zaprinast

Indexed keywords

ENPROFYLLINE; ISOENZYME; ISOPRENALINE; METHACHOLINE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SIGUAZODAN; VINPOCETINE; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; ILEUM CONTRACTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029786358     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15653.x     Document Type: Article

References (33)

1. BARBIER, A.J. & LEFEBVRE, R.A (1995). Relaxant influence of phosphodiesterase inhibitors in the cat gastric fundus. Eur. J. Pharmacol., 276, 41-47.
2. BARNETTE, M.S., BARONE, F.C., GROUSE, M., TORPHY, T.J. & ORMSBEE III, H.S. (1988). Smooth muscle cyclic GMP (cGMP) is elevated by activating enteric neurones in the lower esophageal sphincter (LES) muscle of three species. Gastroenterology, 95, 855.
3. BARNETTE, M.S., GROUSE, M., TORPHY, T.J. & ORMSBEE III, H.S. (1990). Activation of cyclic AMP-independent protein kinase during canine lower esophageal sphincter relaxation. J. Pharmacol. Exp. Ther., 252, 1160-1166.
4. BARNETTE, M.S., MANNING, C.D., PRICE, W.J. & BARONE, F.C. (1993). Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle. J. Pharmacol. Exp. Ther., 264, 801-812.
5. BARNETTE, M.S., TORPHY, T.J., GROUSE, M., FINE, C. & ORMSBEE III, H.S. (1989). Cyclic GMP: A potential mediator of neurally-and drug-induced relaxation of opossum lower esophageal sphincter. J. Pharmacol. Exp. Ther., 249, 524-529.
6. BEAVO, J.A. & REIFSNYDER, D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 150-155.
7. BEWLEY, J.S. & CHAPMAN, I.D. (1988). AH 21-132 a novel relaxant of airway smooth muscle. Br. J. Pharmacol., 93, 52P.
8. DENT, G., MAGNUSSEN, M. & RABE, K.F. (1994). Cyclic nucleotide phosphodiesterases in the human lung. Lung, 172, 129-146.
9. GIEMBYCZ, M.A. & RAEBURN, D. (1991). Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J. Auton. Pharmacol., 11, 365-398.
10. GRASSBY, P.F. & BROADLEY, K.J. (1984). Characterization of β-adrenoceptors mediating relaxation of the guinea pig ileum. J. Pharm. Pharmacol., 36, 602-607.
11. GROUSE, M., JOSLYN, A.F., THOMPSON, W. & BARNETTE, M.S.(1991). Change in intracellular cyclic nucleotide content accompanies relaxation of the isolated canine internal and anal sphincter. J. Gastrointest. Motil., 3, 46-52.
12. HARRIS, A.L., CONNELL, M.J., FERGUSON, E.W., WALLACE, A.M., GORDON, R.J., PAGANI, E.D. & SILVER, P.J. (1989). Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J. Pharmacol. Exp. Ther., 251, 199-206.
13. JOSLYN, A.F., BARNETTE, M.S., GROUSE, M., FUDGE, M., PRICE, W.J., MANNING, C.D., THOMPSON, W.E, BARONE, F.C. & ORMSBEE III, H.S. (1990). Cyclic nucleotides increase during neuronally induced relaxation of sphincteric gastrointestinal smooth muscle. J. Gastrointest. Motil., 2, 65-72.
14. JOSLYN, A.F., FUDGE, M., BARNETTE, M.S., MANNING, C.D., BARONE, F.C. & ORMSBEE III, H.S. (1988). Relaxation of guinea-pig proximal colon (PC) and taenia coli (TC) smooth muscle is regulated by cyclic nucleotide (CN) content. Gastroenterology, 94, A212.
15. KARLSSON, J-A., SOUNESS, J., RAEBURN, D., PALFREYMAN, M. & ASHTON, M. (1993). Anti-inflammatory effects of novel selective cyclic nucleotide phosphodiesterase inhibitors. In T-Lymphocyte and Inflammatory Cell Research in Asthma, ed. Jolles, G., Karlsson, J-A. & Taylor, J. pp. 323-351. London: Academic Press Ltd.
16. LANDGRAF, W., RUTH, P., KEILBACH, A., MAY, B., WELLING, A. & HOFMANN, F. (1992). Cyclic GMP-dependent protein kinase and smooth muscle relaxation. J. Cardiovasc. Pharmacol., 20, S18-S22.
17. 2+ by cyclic AMP in vascular smooth muscle cells. Am. J. Physiol., 258, C399-C407.
18. MURRAY, K.J. (1990). Cyclic AMP and mechanisms of vasodilation. Pharmacol. Ther., 47, 329-345.
19. NICHOLSON, C.D. (1990). Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology, 101, 147-159.
20. NICHOLSON, C.D. & CHALLISS, R.A.J. (1991). Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends. Pharmacol. Sci., 12, 19-27.
21. NICHOLSON, C.D. & SHAHID, M. (1994). Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes-their potential utility in the therapy of asthma. Pulm. Pharmacol., 7, 1-17.
22. PODZUWEIT, T. & MULLER, A. (1993). Anti-arrythmic effects of selective inhibition of myocardial phosphodiesterase II. Lancet, 341, 760.
23. RAEBURN, D., SOUNESS, J.E., TOMKINSON, A. & KARLSSON, J-A. (1993). Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: Biochemistry, pharmacology and therapeutic potential in asthma. Progress Drug Res., 40, 9-32.
24. RATTAN, S. & MOUMMI, C. (1989). Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter. J. Pharmacol. Exp. Ther., 248, 703-709.
25. SMALL, R.C., BOYLE, J.P., DUTY, S., ELLIOT, K.R.F., FOSTER, R.W. & WATT, A.J. (1989a). Analysis of the relaxant effects of AH21-132 in guinea pig isolated trachealis. Br. J. Pharmacol., 97, 1165-1173.
26. SMALL, R.C., BOYLE, J.P., ELLIOTT, K.R.F., FOSTER, R.W. & WATT, A.J. (1989b). Inhibitory effects of AH21-132 in guinea pig isolated ileum and taenia caeci. Br. J. Pharmacol., 97, 1174-1181.
27. TAKAGI, K., OGAWA, K., TANAKA, H., SATAKE, T., WATANABE, Y., CHIJIWA, T. & HIDAKA, H. (1992). Relaxant effects of various xanthine derivatives: Relationship to cyclic nucleotide phosphodiesterase inhibition. In Advances in Second Messenger and Phosphoprotein Research Vol., 25, ed. Strada, S.J. & Hidaka, H. New York: Raven Press Ltd.
28. THOMPSON, W.J. (1991). Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function. Pharmacol. Ther., 51, 13-33.
29. TOMKINSON, A., KARLSSON, J-A. & RAEBURN, D. (1993). Comparison of the effects of selective inhibitors of phosphodiesterase types III and IV in airway smooth muscle with differing β-adrenoceptor subtypes. Br. J. Pharmacol., 108, 57-61.
30. TOMKINSON, A. & RAEBURN, D. (1995). The effect of isozyme selective phosphodiesterase inhibitors on methacholine-induced contraction of guinea-pig ileum. Br. J. Pharmacol., 114, 437P.
31. UKENA, D., SCHUDT, C. & SYBRECHT, G.W. (1993). Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes. Biochem. Pharmacol., 45, 847-851.
32. UNDERWOOD, D.C., KOTZER, C.J., BOCHNOWICZ, S., OSBORN, R.T., LUTTMANN, M.A., HAY, D.W.P. & TORPHY, T.J. (1994). Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea-pigs. J. Pharmacol. Exp. Ther., 270, 250-259.
33. WALDMAN, S.A. & MURAD, F. (1987). Cyclic GMP synthesis and function. Pharmacol. Rev., 39, 163-196.